Nonsteroidal anti-inflammatory drugs use in patients with chronic kidney disease are often prescribed from different clinicians than those who diagnosed them

作者: Shungo Imai , Kenji Momo , Hitoshi Kashiwagi , Takayuki Miyai , Mitsuru Sugawara

DOI: 10.1002/PDS.5027

关键词:

摘要: Purpose When prescribing nonsteroidal anti-inflammatory drugs (NSAIDs) for chronic kidney disease (CKD), patients' pathology and concomitant medications should be considered. In our pharmaceutical experience, NSAIDs are often prescribed by departments that different from those diagnosed CKD. That is, may patients without the advice of clinicians who them. this study, we aimed to elucidate how frequently such cases occur. Methods We used large health insurance claims database constructed JMDC Inc., Tokyo. evaluated proportions CKD diagnosis NSAID prescription clinical institutions. Results A total 224 014 out-patients were included in analysis; they divided into (n = 1501) non-CKD groups 222 513). The internal medicine most (74.8% patients) surgical rarely However, proportion was high other departments, especially departments. group, 50.4% received departments; 72.8% a medical Conclusion Our study revealed with than

参考文章(18)
D.H. Adams, J. Michael, P.A. Bacon, A.J. Howie, B. Mcconkey, D. Adu, Non-steroidal anti-inflammatory drugs and renal failure. The Lancet. ,vol. 327, pp. 57- 60 ,(1986) , 10.1016/S0140-6736(86)90714-2
Hans-Henrik Parving, Hendrik Lehnert, Jens Bröchner-Mortensen, Ramon Gomis, Steen Andersen, Peter Arner, The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. The New England Journal of Medicine. ,vol. 345, pp. 870- 878 ,(2001) , 10.1056/NEJMOA011489
Katherine Gooch, Bruce F. Culleton, Braden J. Manns, Jianguo Zhang, Helman Alfonso, Marcello Tonelli, Cy Frank, Scott Klarenbach, Brenda R. Hemmelgarn, NSAID Use and Progression of Chronic Kidney Disease The American Journal of Medicine. ,vol. 120, ,(2007) , 10.1016/J.AMJMED.2006.02.015
for the RENAAL Study Investigators* Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Parving HH, Remuzzi G, Snapinn S, Zhang X, Shahinfar S, None, EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY The New England Journal of Medicine. ,vol. 345, pp. 861- 869 ,(2001) , 10.1056/NEJMOA011161
Ta-Wei Hsu, Jia-Sin Liu, Szu-Chun Hung, Ko-Lin Kuo, Yu-Kang Chang, Yu-Chi Chen, Chih-Cheng Hsu, Der-Cherng Tarng, Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia JAMA Internal Medicine. ,vol. 174, pp. 347- 354 ,(2014) , 10.1001/JAMAINTERNMED.2013.12700
Dale P Sandler, F Rebecca Burr, Clarice R Weinberg, Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease Annals of Internal Medicine. ,vol. 115, pp. 165- 172 ,(1991) , 10.7326/0003-4819-115-3-165
Søren Lund Kristensen, Emil L. Fosbøl, Anne-Lise Kamper, Lars Køber, Kristine Hommel, Morten Lamberts, Steen Z. Abildstrøm, Thalia M. Blicher, Christian Torp-Pedersen, Gunnar H. Gislason, Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study. Pharmacoepidemiology and Drug Safety. ,vol. 21, pp. 428- 434 ,(2012) , 10.1002/PDS.3227
Sally Hull, Rohini Mathur, Gavin Dreyer, Muhammad Magdi Yaqoob, Evaluating ethnic differences in the prescription of NSAIDs for chronic kidney disease: a cross-sectional survey of patients in general practice. British Journal of General Practice. ,vol. 64, ,(2014) , 10.3399/BJGP14X680557
Laura Plantinga, Vanessa Grubbs, Urmimala Sarkar, Chi-yuan Hsu, Elizabeth Hedgeman, Bruce Robinson, Rajiv Saran, Linda Geiss, Nilka Ríos Burrows, Mark Eberhardt, Neil Powe, Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States Annals of Family Medicine. ,vol. 9, pp. 423- 430 ,(2011) , 10.1370/AFM.1302